| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |